{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:30:15Z","timestamp":1772166615454,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","award":["Rigshospitalet"],"award-info":[{"award-number":["Rigshospitalet"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010347","name":"Fabrikant Einar Willumsens Mindelegat","doi-asserted-by":"publisher","award":["Fabrikant Einar Willumsens Mindelegat"],"award-info":[{"award-number":["Fabrikant Einar Willumsens Mindelegat"]}],"id":[{"id":"10.13039\/501100010347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","award":["Aase og Ejnar Danielsens Fond"],"award-info":[{"award-number":["Aase og Ejnar Danielsens Fond"]}],"id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-025-01362-z","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:04:56Z","timestamp":1768341896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiogenesis PET\/MRI predicts initial growth of sporadic vestibular schwannomas: a prospective study with follow-up in 29 patients using [68Ga]Ga-NODAGA-E[c(RGDyK)]2"],"prefix":"10.1186","volume":"16","author":[{"given":"Hjalte C. R.","family":"Sass","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon G.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle H.","family":"Johannesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan O.","family":"L\u00f6fgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Loft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Cay\u00e9-Thomasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"2","key":"1362_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1017\/S0022215107001028","volume":"122","author":"T Khrais","year":"2008","unstructured":"Khrais T, Romano G, Sanna M. Nerve origin of vestibular schwannoma: a prospective study. J Laryngol Otol. 2008;122(2):128\u201331. https:\/\/doi.org\/10.1017\/S0022215107001028.","journal-title":"J Laryngol Otol"},{"key":"1362_CR2","doi-asserted-by":"crossref","unstructured":"Gareth Evans DR, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R. Incidence of Vestibular Schwannoma and Neurofibromatosis 2 in the North West of England over a 10-Year Period: Higher Incidence than Previously Thought.; 2005.","DOI":"10.1097\/00129492-200501000-00016"},{"key":"1362_CR3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/CLEP.S218670","volume":"11","author":"M Reznitsky","year":"2019","unstructured":"Reznitsky M, Petersen MMBS, West N, Stangerup SE, Cay\u00e9-Thomasen P. Epidemiology of vestibular schwannomas \u2013 prospective 40-year data from an unselected National cohort. Clin Epidemiol. 2019;11:981\u20136. https:\/\/doi.org\/10.2147\/CLEP.S218670.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"1362_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0385-8146(00)00093-6","volume":"28","author":"E Kentala","year":"2001","unstructured":"Kentala E, Pyykk\u00f6 I. Clinical picture of vestibular schwannoma. Auris Nasus Larynx. 2001;28(1):15\u201322 (doi:S0385-8146(00)00093-6 [pii]).","journal-title":"Auris Nasus Larynx"},{"issue":"4","key":"1362_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMC2108279","volume":"385","author":"N Beucler","year":"2021","unstructured":"Beucler N, Lalya I, Essadi I. Vestibular schwannomas. N Engl J Med. 2021;385(4):380\u20132. https:\/\/doi.org\/10.1056\/NEJMC2108279.","journal-title":"N Engl J Med"},{"issue":"10","key":"1362_CR6","doi-asserted-by":"publisher","first-page":"e1360","DOI":"10.1097\/MAO.0000000000002917","volume":"41","author":"ML Carlson","year":"2020","unstructured":"Carlson ML, Link MJ, Driscoll CLW, et al. Working toward consensus on sporadic vestibular schwannoma care: a modified Delphi study. Otol Neurotol. 2020;41(10):e1360\u201371. https:\/\/doi.org\/10.1097\/MAO.0000000000002917.","journal-title":"Otol Neurotol"},{"issue":"5","key":"1362_CR7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/NEUONC\/NOAA230","volume":"23","author":"M Reznitsky","year":"2020","unstructured":"Reznitsky M, Petersen MMBS, West N, Stangerup SE, Cay\u00e9-Thomasen P. The natural history of vestibular schwannoma growth\u2014prospective 40-year data from an unselected National cohort. Neuro Oncol. 2020;23(5):827. https:\/\/doi.org\/10.1093\/NEUONC\/NOAA230.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1362_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11060-016-2292-9","volume":"131","author":"HCR Sass","year":"2017","unstructured":"Sass HCR, Borup R, Alanin M, Nielsen FC, Cay\u00e9-Thomasen P. Gene expression, signal transduction pathways and functional networks associated with growth of sporadic vestibular schwannomas. J Neurooncol. 2017;131(2):283\u201392. https:\/\/doi.org\/10.1007\/s11060-016-2292-9.","journal-title":"J Neurooncol"},{"issue":"4","key":"1362_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/lary.20834","volume":"120","author":"MN M\u00f8ller","year":"2010","unstructured":"M\u00f8ller MN, Werther K, Nalla A, et al. Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1. Laryngoscope. 2010;120(4):657\u201362. https:\/\/doi.org\/10.1002\/lary.20834.","journal-title":"Laryngoscope"},{"issue":"1","key":"1362_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00129492-200501000-00017","volume":"26","author":"P Cay\u00e9-Thomasen","year":"2005","unstructured":"Cay\u00e9-Thomasen P, Werther K, Nalla A, et al. VEGF and VEGF receptor-1 concentration in vestibular Schwannoma homogenates correlates to tumor growth rate. Otol Neurotol. 2005;26(1):98\u2013101. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15699727.","journal-title":"Otol Neurotol"},{"key":"1362_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/GB-2007-8-5-215","author":"Y Takada","year":"2007","unstructured":"Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007. https:\/\/doi.org\/10.1186\/GB-2007-8-5-215.","journal-title":"Genome Biol"},{"issue":"6","key":"1362_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/J.HUMPATH.2005.03.014","volume":"36","author":"M Lim","year":"2005","unstructured":"Lim M, Guccione S, Haddix T, et al. \u03b1v\u03b23 integrin in central nervous system tumors. Hum Pathol. 2005;36(6):665\u20139. https:\/\/doi.org\/10.1016\/J.HUMPATH.2005.03.014.","journal-title":"Hum Pathol"},{"issue":"6","key":"1362_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/DDR.20265","volume":"69","author":"Z Liu","year":"2008","unstructured":"Liu Z, Wang F, Chen X. Integrin \u03b1v\u03b23-Targeted cancer therapy. Drug Dev Res. 2008;69(6):329. https:\/\/doi.org\/10.1002\/DDR.20265.","journal-title":"Drug Dev Res"},{"key":"1362_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2013.12.003","author":"J Oxboel","year":"2014","unstructured":"Oxboel J, Brandt-Larsen M, Schjoeth-Eskesen C, et al. Comparison of two new angiogenesis PET tracers 68 Ga-NODAGA-E[c(RGDyK)] 2 and 64 Cu-NODAGA-E[c(RGDyK)] 2; in vivo imaging studies in human xenograft tumors. Published Online. 2014. https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.12.003.","journal-title":"Published Online"},{"issue":"supplement 2","key":"1362_CR15","first-page":"1367","volume":"57","author":"J Oxboel","year":"2016","unstructured":"Oxboel J, Brandt-Larsen M, Madsen J, Kjaer A. Uptake of the angiogenesis PET tracer 68Ga-NODAGA-E[c(RGDyK)]2 correlates strongly with Angiopoietin-1 and Angiopoietin-2 expression in human neuroendocrine xenograft tumors in mice. J Nucl Med. 2016;57(supplement 2):1367\u20131367. https:\/\/jnm.snmjournals.org\/content\/57\/supplement_2\/1367. Accessed August 7, 2024.","journal-title":"J Nucl Med"},{"key":"1362_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/DIAGNOSTICS11101807","author":"S Bentsen","year":"2021","unstructured":"Bentsen S, Clemmensen A, Loft M, et al. [68Ga]Ga-NODAGA-E[(cRGDyK)]2 Angiogenesis PET\/MR in a Porcine Model of Chronic Myocardial Infarction. Diagnostics. 2021. https:\/\/doi.org\/10.3390\/DIAGNOSTICS11101807.","journal-title":"Diagnostics"},{"issue":"2","key":"1362_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/S00259-020-04881-0","volume":"48","author":"A Clemmensen","year":"2021","unstructured":"Clemmensen A, Hansen AE, Holst P, et al. [68Ga]Ga-NODAGA-E[(cRGDyK)]2 PET and hyperpolarized [1-13\u00a0C] pyruvate MRSI (hyperPET) in canine cancer patients: simultaneous imaging of angiogenesis and the Warburg effect. Eur J Nucl Med Mol Imaging. 2021;48(2):395. https:\/\/doi.org\/10.1007\/S00259-020-04881-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1362_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.nucmedbio.2013.12.003","volume":"41","author":"J Oxboel","year":"2014","unstructured":"Oxboel J, Brandt-Larsen M, Schjoeth-Eskesen C, et al. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and 64Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors. Nucl Med Biol. 2014;41(3):259\u201367. https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.12.003.","journal-title":"Nucl Med Biol"},{"key":"1362_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12040851","author":"MM Clausen","year":"2022","unstructured":"Clausen MM, Carlsen EA, Christensen C, et al. First-in-human study of [ 68 Ga]Ga-NODAGA-E[c(RGDyK)] 2 PET for integrin \u03b1 v \u03b2 3 imaging in patients with breast cancer and neuroendocrine neoplasms: safety, dosimetry and tumor imaging ability. Diagnostics. 2022. https:\/\/doi.org\/10.3390\/diagnostics12040851.","journal-title":"Diagnostics"},{"issue":"2","key":"1362_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2967\/JNUMED.122.264383","volume":"64","author":"EA Carlsen","year":"2023","unstructured":"Carlsen EA, Loft M, Loft A, et al. Prospective phase II trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET\/CT imaging of integrin \u03b1v\u03b23 for prognostication in patients with neuroendocrine neoplasms. J Nucl Med. 2023;64(2):252. https:\/\/doi.org\/10.2967\/JNUMED.122.264383.","journal-title":"J Nucl Med"},{"issue":"4","key":"1362_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/neuonc\/noae252","volume":"27","author":"SM Schouten","year":"2025","unstructured":"Schouten SM, Lewis D, Cornelissen S, et al. Dynamic contrast-enhanced and diffusion-weighted MR imaging for predicting tumor growth of sporadic vestibular schwannomas: a prospective study. Neuro Oncol. 2025;27(4):1116\u201327. https:\/\/doi.org\/10.1093\/neuonc\/noae252.","journal-title":"Neuro Oncol"},{"issue":"20","key":"1362_CR22","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/60\/20\/8047","volume":"60","author":"CN Ladefoged","year":"2015","unstructured":"Ladefoged CN, Benoit D, Law I, et al. Region specific optimization of continuous linear attenuation coefficients based on UTE (RESOLUTE): application to PET\/MR brain imaging. Phys Med Biol. 2015;60(20):8047. https:\/\/doi.org\/10.1088\/0031-9155\/60\/20\/8047.","journal-title":"Phys Med Biol"},{"key":"1362_CR23","doi-asserted-by":"publisher","first-page":"e081123","DOI":"10.1136\/bmj-2024-081123","volume":"389","author":"S Hopewell","year":"2025","unstructured":"Hopewell S, Chan AW, Collins GS, et al. CONSORT 2025 statement: updated guideline for reporting randomised trials. BMJ. 2025;389:e081123. https:\/\/doi.org\/10.1136\/bmj-2024-081123.","journal-title":"BMJ"},{"issue":"3","key":"1362_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/neuonc\/noy177","volume":"21","author":"D Lewis","year":"2019","unstructured":"Lewis D, Roncaroli F, Agushi E, et al. Inflammation and vascular permeability correlate with growth in sporadic vestibular Schwannoma. Neuro Oncol. 2019;21(3):314\u201325. https:\/\/doi.org\/10.1093\/neuonc\/noy177.","journal-title":"Neuro Oncol"},{"issue":"2","key":"1362_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.otc.2011.12.008","volume":"45","author":"SE Stangerup","year":"2012","unstructured":"Stangerup SE, Caye-Thomasen P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am Elsevier Inc. 2012;45(2):257\u201368. https:\/\/doi.org\/10.1016\/j.otc.2011.12.008.","journal-title":"Otolaryngol Clin North Am Elsevier Inc"},{"issue":"3","key":"1362_CR26","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/0194599815590105","volume":"153","author":"ML Carlson","year":"2015","unstructured":"Carlson ML, Habermann EB, Wagie AE, et al. The changing landscape of vestibular Schwannoma management in the united States\u2014A shift toward conservatism. Otolaryngology\u2013Head Neck Surg. 2015;153(3):440\u20136. https:\/\/doi.org\/10.1177\/0194599815590105.","journal-title":"Otolaryngology\u2013Head Neck Surg"},{"issue":"6","key":"1362_CR27","first-page":"1","volume":"26","author":"M Reznitsky","year":"2015","unstructured":"Reznitsky M. The natural history of vestibular Schwannoma growth - prospective 40-year data from an unselected National cohort. Eur Neuropsychopharmacol. 2015;26(6):1\u201315.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1362_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-020-04238-4","author":"HCR Sass","year":"2020","unstructured":"Sass HCR, Hansen M, Borup R, Nielsen FC, Cay\u00e9-Thomasen P. Tumor miRNA expression profile is related to vestibular schwannoma growth rate. Acta Neurochir (Wien). 2020. https:\/\/doi.org\/10.1007\/s00701-020-04238-4.","journal-title":"Acta Neurochir (Wien)"},{"issue":"December","key":"1362_CR29","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1097\/00005537-200312000-00014","volume":"113","author":"P Cay\u00e9-Thomasen","year":"2003","unstructured":"Cay\u00e9-Thomasen P, Baandrup L, Jacobsen GK, Thomsen J, Stangerup SE. Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate. Laryngoscope. 2003;113(December):2129\u201334. https:\/\/doi.org\/10.1097\/00005537-200312000-00014.","journal-title":"Laryngoscope"},{"issue":"2","key":"1362_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/MAO.0b013e3181be6478","volume":"31","author":"P Cay\u00e9-Thomasen","year":"2010","unstructured":"Cay\u00e9-Thomasen P, Borup R, Stangerup SE, Thomsen J, Nielsen FC. Deregulated genes in sporadic vestibular schwannomas. Otol Neurotol. 2010;31(2):256\u201366. https:\/\/doi.org\/10.1097\/MAO.0b013e3181be6478.","journal-title":"Otol Neurotol"},{"issue":"5","key":"1362_CR31","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/00129492-200409000-00024","volume":"25","author":"BF O\u2019Reilly","year":"2004","unstructured":"O\u2019Reilly BF, Kishore A, Crowther Ja, Smith C. Correlation of growth factor receptor expression with clinical growth in vestibular schwannomas. Otol Neurotol. 2004;25(5):791\u20136. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15354013.","journal-title":"Otol Neurotol"},{"issue":"8","key":"1362_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/MAO.0b013e31814b2787","volume":"28","author":"D Koutsimpelas","year":"2007","unstructured":"Koutsimpelas D, Stripf T, Heinrich UR, Mann WJ, Brieger J. Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics. Otol Neurotol. 2007;28(8):1094\u20139. https:\/\/doi.org\/10.1097\/MAO.0b013e31814b2787.","journal-title":"Otol Neurotol"},{"issue":"2","key":"1362_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/MAO.0b013e31827c9fbf","volume":"34","author":"M De Vries","year":"2013","unstructured":"De Vries M, Briaire-De Bruijn I, Malessy MJA, De Bru\u00efne SFT, Van Der Mey AGL, Hogendoorn PCW. Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas. Otology Neurotology. 2013;34(2):347\u201352. https:\/\/doi.org\/10.1097\/MAO.0b013e31827c9fbf.","journal-title":"Otology Neurotology"},{"issue":"2","key":"1362_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11060-005-2886-0","volume":"75","author":"HJ Seol","year":"2005","unstructured":"Seol HJ, Jung HW, Park SH, et al. Aggressive vestibular schwannomas showing postoperative rapid growth - their association with decreased p27 expression. J Neurooncol. 2005;75(2):203\u20137. https:\/\/doi.org\/10.1007\/s11060-005-2886-0.","journal-title":"J Neurooncol"},{"issue":"3","key":"1362_CR35","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/0008-5472.CAN-10-1219","volume":"71","author":"O Saydam","year":"2011","unstructured":"Saydam O, Senol O, W\u00fcrdinger T, et al. MiRNA-7 attenuation in schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res. 2011;71(3):852\u201361. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1219.","journal-title":"Cancer Res"},{"issue":"3","key":"1362_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00428-018-2503-1","volume":"474","author":"WM de Vries","year":"2019","unstructured":"de Vries WM, Briaire-de Bruijn IH, van Benthem PPG, van der Mey AGL, Hogendoorn PCW. M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma. Virchows Arch. 2019;474(3):375\u201381. https:\/\/doi.org\/10.1007\/s00428-018-2503-1.","journal-title":"Virchows Arch"},{"issue":"1","key":"1362_CR37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3892\/mmr.2015.3415","volume":"12","author":"S Taurone","year":"2015","unstructured":"Taurone S, Bianchi E, Attanasio G, et al. Immunohistochemical profile of cytokines and growth factors expressed in vestibular schwannoma and in normal vestibular nerve tissue. Mol Med Rep. 2015;12(1):737\u201345. https:\/\/doi.org\/10.3892\/mmr.2015.3415.","journal-title":"Mol Med Rep"},{"issue":"3","key":"1362_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13030466","volume":"13","author":"VM Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves VM, Suhm EM, Ries V, et al. Macrophage and lymphocyte infiltration is associated with volumetric tumor size but not with volumetric growth in the t\u00fcbingen Schwannoma cohort. Cancers (Basel). 2021;13(3):1\u201315. https:\/\/doi.org\/10.3390\/cancers13030466.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"1362_CR39","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1201\/B23252-48","volume":"67","author":"F Arnold","year":"1985","unstructured":"Arnold F. Tumour angiogenesis. Ann R Coll Surg Engl. 1985;67(5):295\u20138. https:\/\/doi.org\/10.1201\/B23252-48.","journal-title":"Ann R Coll Surg Engl"},{"issue":"7","key":"1362_CR40","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41390-020-01177-9","volume":"89","author":"OJ Mezu-Ndubuisi","year":"2021","unstructured":"Mezu-Ndubuisi OJ, Maheshwari A. The role of integrins in inflammation and angiogenesis. Pediatr Res Springer Nature. 2021;89(7):1619\u201326. https:\/\/doi.org\/10.1038\/s41390-020-01177-9.","journal-title":"Pediatr Res Springer Nature"},{"issue":"7","key":"1362_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS13071711","volume":"2021","author":"BS Ludwig","year":"2021","unstructured":"Ludwig BS, Kessler H, Kossatz S, Reuning U. RGD-binding integrins revisited: how recently discovered functions and novel synthetic ligands (Re-)shape an ever-evolving field. Cancers. 2021;2021(7):1711. https:\/\/doi.org\/10.3390\/CANCERS13071711.","journal-title":"Cancers"},{"issue":"9","key":"1362_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS9090116","volume":"2017","author":"M Nieberler","year":"2017","unstructured":"Nieberler M, Reuning U, Reichart F, et al. Exploring the role of RGD-recognizing integrins in cancer. Cancers. 2017;2017(9):116. https:\/\/doi.org\/10.3390\/CANCERS9090116.","journal-title":"Cancers"},{"issue":"5158","key":"1362_CR43","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/SCIENCE.7512751","volume":"264","author":"PC Brooks","year":"1994","unstructured":"Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin \u03b1v\u03b23 for angiogenesis. Sci (1979). 1994;264(5158):569\u201371. https:\/\/doi.org\/10.1126\/SCIENCE.7512751.","journal-title":"Sci (1979)"},{"issue":"6","key":"1362_CR44","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00428-012-1236-9","volume":"460","author":"M De Vries","year":"2012","unstructured":"De Vries M, Hogendoorn PCW, De Bruyn IB, Malessy MJA, Van Der Mey AGL. Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas. Virchows Arch. 2012;460(6):629\u201336. https:\/\/doi.org\/10.1007\/s00428-012-1236-9.","journal-title":"Virchows Arch"},{"key":"1362_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2019.7.JNS19879","volume":"4","author":"A Perry","year":"2019","unstructured":"Perry A, Graffeo CS, Carlstrom LP, et al. Predominance of M1 subtype among tumor-associated macrophages in phenotypically aggressive sporadic vestibular Schwannoma. J Neurosurg Published Online Oct. 2019;4:1\u20139. https:\/\/doi.org\/10.3171\/2019.7.JNS19879.","journal-title":"J Neurosurg Published Online Oct"},{"key":"1362_CR46","doi-asserted-by":"publisher","unstructured":"Hannan C, Lewis D, O\u2019leary C et al. The inflammatory microenvironment in vestibular Schwannoma. https:\/\/doi.org\/10.1093\/noajnl\/vdaa023\/5760813","DOI":"10.1093\/noajnl\/vdaa023\/5760813"},{"key":"1362_CR47","doi-asserted-by":"publisher","unstructured":"Lewis D, Donofrio CA, O\u2019Leary C et al. The microenvironment in sporadic and neurofibromatosis type II\u2013related vestibular schwannoma: the same tumor or different? A comparative imaging and neuropathology study. J Neurosurg Published Online May 2020:1\u201311. https:\/\/doi.org\/10.3171\/2020.3.JNS193230","DOI":"10.3171\/2020.3.JNS193230"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01362-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01362-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01362-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:30:52Z","timestamp":1770647452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-025-01362-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1362"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01362-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7415784\/v1","asserted-by":"object"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Danish Health and Medicine Authority (EudraCT no. 2017-002604-27) and the Regional Scientific Ethical Committee (H-17024682) and registered at ClinicalTrials.gov (NCT03393689). The study was performed in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP) and independently monitored by the GCP unit of the Capital Region of Denmark. All participants signed informed consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to participate and publication of results were obtained from all individuals included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Andreas Kj\u00e6r MD, PhD, DMSc, holds a patent for the PET-MRI tracer [\n                      68\n                      Ga]Ga-NODAGA-E[c(RGDyK)]\n                      2\n                      with publication number 20200282084. No other potential conflicts of interest relevant to this article exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}